The existence of a biochemical threshold effect in the metabolic expression of oxidative phosphorylation deficiencies has considerable implications for the understanding of mitochondrial bioenergetics and the study of mitochondrial diseases. However, the molecular bases of this phenomenon remain unclear. We report here a new mechanism to explain this threshold effect, based on a reserve of enzymes not initially participating in the respiratory rate that can be activated either to respond to a flux increase or to compensate for a defect induced by a mutation. We show that this mobilization occurs through 1) the assembly of inactive adenine nucleotide translocator isoform 1 subunits into oligomeric active carriers or 2) conformational changes in the adenine nucleotide translocator isoform 1 in a permeability transition pore-like structure. We discuss how these transitions are sensitive to the steady state of oxidative phosphorylation functioning or tissue and analyze their consequences on the threshold effect.
From the INSERM, Université Victor Segalen-Bordeaux 2, F-33076 Bordeaux Cedex, France
The existence of a biochemical threshold effect in the metabolic expression of oxidative phosphorylation deficiencies has considerable implications for the understanding of mitochondrial bioenergetics and the study of mitochondrial diseases. However, the molecular bases of this phenomenon remain unclear. We report here a new mechanism to explain this threshold effect, based on a reserve of enzymes not initially participating in the respiratory rate that can be activated either to respond to a flux increase or to compensate for a defect induced by a mutation. We show that this mobilization occurs through 1) the assembly of inactive adenine nucleotide translocator isoform 1 subunits into oligomeric active carriers or 2) conformational changes in the adenine nucleotide translocator isoform 1 in a permeability transition pore-like structure. We discuss how these transitions are sensitive to the steady state of oxidative phosphorylation functioning or tissue and analyze their consequences on the threshold effect.
The role of mitochondria in mammalian cells is generally presented as a "central pathway" for energy metabolism, but other important aspects of mitochondrial function have also been evidenced, such as its key role in apoptosis, free radical production, thermogenesis, and calcium signaling. Consequently, impairments of mitochondrial function have been associated with the emergence of severe human disorders, known as mitochondrial cytopathies (1, 2) . Despite a broad characterization of the genetic defects leading to mitochondrial disorders, few of their pathogenetic mechanisms are fully understood. In particular, the relationship between the presence of an activity defect in a given OXPHOS 1 complex and its effect on mitochondrial energy production remains problematic. Indeed, several authors have showed that it was possible to inhibit the activity of various OXPHOS complexes, up to a critical value, without affecting the rate of mitochondrial respiration or ATP synthesis (3) . This phenomenon is called the "biochemical threshold effect" (4) . It partially controls the phenotypic expression of OXPHOS defects and therefore contributes to the variability in the clinical presentation of mitochondrial disorders. It has also been reported that a variation in the biochemical threshold value between tissues explains part of the tissue specificity observed in mitochondrial diseases (5) . Thus, finding the molecular mechanisms that determine the threshold value and its variability will contribute to a better understanding of the pathogenesis of mitochondrial cytopathies and help to design new therapeutic approaches (6) .
One possible mechanism for the biochemical threshold effect is the existence of an excess of inactive OXPHOS complexes that may act as a "reserve" to compensate for a deficit (5, 7) . In this study, we tested the hypothesis that the biochemical threshold effect resulted from the mobilization of a pool of inactive OXPHOS enzymes. We also analyzed how this process varied in different tissues, enzyme isoforms, or respiratory steady states. Our study focused on the adenine nucleotide translocator (ANT) because it is possible to quantify the functional carriers participating actively in respiration using CATR (8 -11) , an irreversible tight binding inhibitor of ANT (12) that binds only to the active form (13, 14) . To study the molecular basis of the ANT reserve, we analyzed the oligomeric state of the ANT1 isoform by blue native-PAGE/modified SDS-PAGE on mitochondria taken during different respiratory steady states obtained with various energy substrates.
Our results give the first molecular explanations for the biochemical threshold effect, based on the excess of activity provided by either 1) a mobilization of inactive ANT1 subunits that assemble into new oligomeric active carriers or 2) conformational changes in ANT1 in a permeability transition porelike structure.
MATERIALS AND METHODS

Animals-Male
Wistar rats used for this study weighed 200 to 300 g and had free access to water and standard laboratory diet. Experimental animals were sacrificed by cervical shock and decapitation.
Mitochondrial Preparations-Rat muscle (gastrocnemius, plantaris, and soleus) and heart mitochondria (15), liver and kidney mitochondria (16) , and brain mitochondria (isolated from whole brain) (17) were isolated as detailed previously. Protein concentration was estimated by the Biuret method (18) using bovine serum albumin as standard. The mitochondria were made up to a concentration of 50 -80 mg of protein/ml in isolation buffer.
Human Muscle Biopsies-Three patients were selected at the Centre Hospitalier Régional de Bordeaux and diagnosed by clinical investigations, biological studies (especially blood lactate and pyruvate), and histo-enzymological studies. Control muscles were taken from patients who underwent muscle biopsy for neuromuscular symptoms but were ultimately found to be free of any mitochondrial disease. Muscle biopsies were performed on the quadriceps muscle under general anesthesia (taken with informed consent of the patients or their parents). Muscle biopsies were stored in 10 ml of ice-cold buffer (10 mM EGTA, 5 mM MgCl 2 , 20 mM taurine, 0.5 mM dithiothreitol, 20 mM imidazol, 0.1 M K ϩ MES, 5 mM ATP, and 20 mM phosphocreatine) and used in the following hour. The mitochondrial respiratory rate was measured on saponin-permeabilized muscle fibers according to the procedures developed by Letellier et al. (19) . Mitochondrial oxygen consumption was measured as described on various respiratory substrates in a medium containing 10 mM EGTA, 5 mM MgCl 2 , 20 mM taurine, 0.5 mM dithiothreitol, 20 mM imidazol, 0.1 M K ϩ MES, 3 mM KH 2 PO 4 , and 5 mg/ml BSA and expressed in natom of oxygen per minute per milligram of fibers.
Oxygraphic Measurements-Mitochondrial oxygen consumption was monitored at 30°C in a 1-ml thermostatically controlled chamber equipped with a Clark oxygen electrode connected to a computer, which gave an on-line display of the respiratory rate value. The respiration buffers used are described in Ref. 5 , plus respiratory substrates (10 mM pyruvate, with 10 mM malate, or 25 mM succinate in presence of 0.4 g/ml rotenone, or 3 mM ascorbate, and 0.5 mM TMPD). The mitochondrial concentration used for this study was 1 mg/ml, and state 3 was obtained as described previously (20) , adding 2 mM ADP. Mitochondrial oxygen consumption was measured as described above on various respiratory substrates and expressed in natom of oxygen per minute per milligram of proteins.
Titration Curves-The titration curves of the step catalyzed by ANT were performed using CATR (Sigma), a derivative of atractyloside, a specific irreversible inhibitor of this step (12) . The inhibition curves were carried out at state 3 on mitochondria respiring on pyruvatemalate, or rotenone-succinate, or ascorbate-TMPD with enough ADP (2 mM) to maintain stable, steady-state respiration. A single concentration of CATR was injected into the oxygraph for one mitochondrial sample at state 3, and then the level of inhibition was recorded. However, because ANT activity is dependent on the ⌬ Hϩ generated by the respiratory chain, it was impossible to determine the activity of the isolated step under the same conditions as for the global flux. For this reason, we used the model presented in Ref. 9 based on a non-linear regression that fits the respiratory rate inhibition curve. The 'Simfit' program was used for nonlinear fitting (21) . Using the parameters obtained by this fitting procedure and the model equations, we drew the inhibition curve of the isolated step activity with the program TK Solver Plus (Universal Technical Systems, Rockford, IL). This model describes the effect of CATR, a noncompetitive inhibitor of ANT, on respiration. By fitting the titration curves with the experimental points, it calculated the total amount of carrier involved in the flux (I max ) but also the inhibition constant of equilibrium (K i ) for CATR, although this model does not take into account the mitochondrial complexity (proton leakage, slippage, other transporters). We had previously validated the use of this model (22) and the experimental and fitted titration curves were identical.
Threshold Curves and Determination of Threshold Value-The threshold curves come from the titration curves and represent the state 3 respiratory rate (percentage) as a function of ANT inhibition (percentage). The threshold values were determined as described by Rossignol et al. (5) . Two linear regressions were carried out on the first and last points of the threshold curve using the least-squares method. We then defined the threshold value as the abscissa of the intersection point between these two regression lines.
Electrophoretic Techniques-Isolated rat mitochondria from muscle and kidney (1 mg/ml) were submitted to oxygraphic measurements at state 3 of respiration on pyruvate-malate, succinate, or ascorbate-TMPD. During this steady state, mitochondria were taken from the oxygraph and centrifuged (20 min, 8000 rpm, 4°C). The pellets were suspended in 1 M 6-aminocaproic acid and 50 mM Bis-Tris. The mitochondrial extracts solubilized by n-dodecylmaltoside or digitonin were centrifuged at 4°C for 30 min at 100,000 ϫ g and the supernatant was immediately loaded on the top of 10% or 5-13% acrylamide-bis gradient gels for BN-PAGE as described previously (23) . The bands were cut and submitted to a second dimension by SDS-PAGE in presence of 1% ␤-mercaptoethanol, modified with a low concentration of SDS (2%). The gel was then subjected to Western blotting.
Western Blots-Mitochondrial proteins with 1 g/ml protease inhibitors (phenylmethylsulfonyl fluoride, leupeptin, and pepstatin) were separated according to different electrophoretic conditions (as described below), electrotransferred to polyvinylidene difluoride membranes (BioRad) and submitted to primary ab in 5% milk. Polyclonal antibodies (abs) specific for human ANT1 isoform (Ab1, amino acids 2-11; Ab2, amino acids 161-171) were purchased from Oncogene Research Products. Polyclonal ANT abs (1:500) were kindly provided by Pr. D. C. Wallace (University of California, Irvine, CA). Abs for Porin (31HL) and cyclophilin D were purchased from Calbiochem and complex II-70 Kda, complex III Core 2, and COX-IV from Molecular Probes. All abs were used at dilutions recommended by the manufacturer. After washing steps, membranes were incubated with horseradish peroxidase-conjugated purified secondary abs (Bio-Rad). Proteins were detected by enhanced chemiluminescence (Amersham Biosciences) and revealed by autoradiography.
Protein Detection and Analysis-The proteins separated by second modified SDS-PAGE dimension were subjected to either Western blotting or staining by Sypro Ruby (Molecular Probes) according to the manufacturer's instructions. Fluorescent proteins were detected with a UV-transilluminator system and recorded by using a Herada 429K digital video camera. The protein spots were cut and subjected to tandem mass spectrometry. Densitometric analysis on Western blots was carried out using NIH Image J software by drawing rectangles around individual spots to quantify their total staining intensity (24) .
RESULTS
Mobilization of ANT and Its Involvement in the Threshold Effect in Different Respiratory
Chain Activities-We quantified the functional ANT participating in different respiratory steady states obtained with various energy substrates (pyruvate-malate, succinate, and ascorbate-TMPD) on mitochondria isolated from five rat tissues (muscle, heart, liver, kidney, and brain) (Fig. 1A) . We titrated mitochondrial respiration by increasing CATR concentrations and determined the amount of inhibitor necessary to inhibit all the carriers involved in the flux (I max ). The Gellerich model (9) was used to determine accurate I max values as well as the inhibition constant (K i ) ( Table I) .
Two groups of tissues were distinguished by their titration curves: liver, kidney, and brain, with a low amount of ANT participating in the respiration on pyruvate-malate (between 0.3 and 0.8 nmol of CATR/mg), and heart and muscle, with at least twice as many carriers (1.5 nmol of CATR/mg). These values are in agreement with earlier results (25) (26) (27) .
More importantly, our results show that the amounts of ANT participating in the flux (I max ) increased in muscle and brain when the respiratory rate was raised ( Fig. 1B and Table I ). In muscle, I max values increased from 1.53 nmol of CATR/mg on pyruvate-malate to 2.89 on succinate and, finally, 4.57 on ascorbate-TMPD. This ANT mobilization also occurred in brain mitochondria, although to a lesser extent (Table I ). The affinity of CATR for ANT (K i ) was statistically similar (p Ͻ 0.05) in all respiratory states, but they were different in tissues for a given steady state (Table I) . These K i values are also in agreement with in vitro work performed on isolated carriers (8, 12) .
The threshold curves obtained for the five tissues on various respiratory substrates presented in Fig. 1B represent the effect of ANT inhibition by CATR on the overall respiratory rate. As previously reported (5), two types of threshold curves (type I and II) have been observed, varying according to tissues and/or respiratory steady states (Fig. 1B) . For instance, muscle and brain, where an increase in I max was observed according to the flux, showed the same curve profile with high threshold values, irrespective of the substrate used (type I curves). Conversely, the curves obtained for liver and kidney varied strongly in shape (type I/type II transition) with lower threshold values ( Fig. 1B and Table I ). The decrease in threshold value was smaller in the case of kidney tissue. Surprisingly, heart was the only tissue to maintain a type I curve without any increase in I max .
To verify whether ANT mobilization also occurred in vivo, we used human muscle fibers taken from biopsies and permeabilized them for respiratory studies using saponin 50 g/ml (19) . CATR titration curves were obtained on pyruvate-malate, succinate, and ascorbate-TMPD ( Fig. 2A) . K i values remained unchanged, whereas I max increased significantly when the respiratory steady state changed (Table I) . This indicated ANT mobilization in muscle fibers, resulting in threshold values over 80% of ANT inhibition, irrespective of the substrate (Fig. 2B) .
Therefore, the increase in functional ANT according to the respiratory flux observed in isolated mitochondria also occurred in living cells and had the same effect on the threshold curves.
Total Amount of ANT and ANT Isoforms 1 and 2 in Different
Tissues-To determine 1) the ANT participating in the respiratory rate, 2) the total amount of carriers, and 3) their com- Example of titration and threshold curves obtained from a single mitochondrial preparation of each tissue. A, state 3 respiratory rate (ADP 2 mM) CATR titration curves from rat mitochondria isolated from different tissues respiring on 10 mM pyruvate and 10 mM malate (f), or 25 mM succinate with 0.4 g/ml rotenone (Ⅺ) or 5 mM ascorbate and 0.3 mM TMPD (OE). Titration curves were fitted according to Ref. 9 . B, threshold curves for the same tissues obtained on pyruvate-malate (line P), succinate (line S), and ascorbate-TMPD (line A). The curves were drawn using the titration curves obtained from the fitting procedure. I max values determined from fitting the titration curves are given for each respiratory substrate in the bar graph, pyruvate-malate (P), succinate (S), and ascorbate-TMPD (A). *, paired t test p Ͻ 0.05 versus I max (without CsA) on pyruvatemalate. **, p Ͻ 0.05 versus succinate for muscle and brain. position in isoforms 1 and 2, we performed Western blotting using ANT polyclonal abs or ANT1 specifics (Ab2). The results show a considerable variation among tissues in the total amount of carriers as well as their ANT1 isoform content (Table II). Muscle and heart had the same absolute amount of total ANT (100%), whereas values in brain (50.6%), kidney (24.7%), and liver (11.7%) were lower ( Fig. 3A and Table II) . Major variations were also observed in the proportion of ANT1 (Fig.  3B) . Thus, rough quantification of the ANT1 tissue expressions were in agreement with the ANT1 mRNA quantification as determined by quantitative PCR (28); we used these mRNA proportions to determine the amount of ANT2 relative to the total carrier content obtained by Western blot. Therefore, we quantified the ANT1 and ANT2 content within the total pool of carriers in each tissue. Isoform 1 was mainly expressed in muscle mitochondria (81.2%), whereas heart contained the highest amount of isoform 2 (37% of total ANT) compared with the other tissues ( Table II) . The distribution of these mRNA isoforms is very similar in rat and human tissues (29) .
Assembly of Inactive ANT1 Monomers When Respiration Is Increased-To visualize the different oligomeric states of ANT and their function in respiratory flux, we solubilized isolated mitochondria in the phosphorylating state of OXPHOS functioning. Muscle mitochondria were withdrawn from the oxygraph during respiratory state 3 on pyruvate-malate in the presence of ADP. Mitochondrial proteins were then solubilized using n-dodecylmaltoside (n-dodecylmaltoside/protein ratio of 1.5 g/g) (30, 31) and separated by BN-PAGE. Western blot analysis identified native complex III (with an apparent molecular mass of 260 kDa), complex IV (200 kDa), complex II (of 120 kDa), and Porin (31 kDa) (Fig. 4A) . Mitochondrial proteins were further separated in a second dimension (modified SDS-PAGE), then immunoblotted with anti-ANT1 (Ab1) and antiPorin. The 2D pattern showed Porin monomers (31 kDa) and two forms of ANT1: a 35-kDa monomer and one in a 200-kDa complex. As the oligomeric form of the carrier (Fig. 4A) required for our analysis could not be maintained under these experimental conditions, we solubilized proteins with a "softer" detergent. We used three concentrations of digitonin (digitonin/ protein ratios of 1, 3, and 6 g/g; data not shown) and performed BN-PAGE/modified SDS-PAGE. Likewise, no difference in the sensitivity to detergent was observed between tissues. The first dimension (with 3 g/g) was analyzed by Western blot, using anti-Porin (31HL) then anti-cytochrome c oxydase IV (Fig. 4B) . On the first dimension, the anti-Porin revealed a first spot at 75 kDa, a second spot at 220 kDa, a third at 300 kDa, and a final spot at more than 300 kDa. The anti-cytochrome c oxydase IV ab revealed the native complex IV at 200 kDa. The Nterminal domain of ANT1 was not recognized by the abs in the first dimension, irrespective of the detergent used (data not shown). Fig. 4B shows the second dimension immunoblotted with anti-Porin (31HL) only (right ge), whereas the left gel was probed with anti-Porin and anti-ANT1 (Ab1). The four spots obtained for Porin clearly established its association in several macrocomplexes: Ͼ300, 300, 220, and 75 kDa. Three forms of ANT1 were identified: 65-kDa dimers (D 1 ), 120-kDa coupled dimers (2D 1 ), and 35-kDa monomers (M 1 ). ANT1 dimer D 1 colocalized with Porin, forming a macrocomplex bigger than 300 kDa. 2D 1 was part of a 220-kDa complex in the first dimension, suggesting an association between 2D 1 and coupled dimeric Porin. ANT1 and Porin monomers (35 and 31 kDa, respectively) also interacted in a 75-kDa complex. Fig. 4C shows a 2D gel obtained under the same conditions as above, except that proteins were detected with Sypro Ruby. Two spots analyzed by tandem mass spectrometry contained mainly ANT1 and Porin (VDAC1) monomers in this 75-kDa complex (Xcorr and sequence recognized for ANT1 from NCBI: 2.614, R.AAYFGVYDTAK.G; VDAC1: 3.36, K.SENGLEFTSSGSANT). To study the relationship between the oligomeric state of ANT and mitochondrial respiration, we used digitonin (3 g/g) to solubilize mitochondrial proteins from muscle, heart, and kidney in various respiratory steady-states (pyruvate-malate, succinate, and ascorbate-TMPD), as well as in the presence of an uncoupler CCCP, and carried out the same 2D gel analysis (Fig. 5A) .
In muscle mitochondria on pyruvate-malate, there were greater amounts of M 1 and 2D 1 than dimers D1 (Fig. 5B) . When the respiratory state was changed by replacing pyruvate with succinate, the proportion of 2D 1 increased (2D 1 /Porin ratio, 0.58 Ϯ 0.15 to 0.94 Ϯ 0.18). When the flux was further increased on ascorbate-TMPD, M 1 was no longer observed, whereas 2D 1 increased strongly compared with D1. It is noteworthy that the addition of carbonylcyanid-m-chlorophenylhydrazon resulted in the uncoupling of respiration and the dissociation of all oligomeric forms of ANT1 and Porin. Indeed, 2D 1 was not detectable after carbonylcyanid-m-chlorophenylhydrazon addition, whereas M 1 increased considerably compared with what was observed on pyruvate-malate (Fig. 5A) . Under   FIG. 2 . ANT mobilization occurs in human muscle after change in respiratory substrates. Example of titration and threshold curves obtained from a single mitochondrial preparation of each tissue. A, human fibers taken from biopsies were permeabilized by saponin, and state 3 respiratory rate (ADP 2 mM) was inhibited by CATR on 10 mM pyruvate and 10 mM malate (f), or 25 mM succinate with 0.4 g/ml rotenone (Ⅺ) or 5 mM ascorbate and 0.3 mM TMPD (OE). B, threshold curves on pyruvate-malate (P), succinate (S), and ascorbate-TMPD (A). Respective I max values obtained from these substrates are indicated in the bar graphs. *, p Ͻ 0.05 versus pyruvate-malate; **, p Ͻ 0.05 versus succinate.
TABLE II ANT1 and ANT2 isoform proportions in different rat tissues
Total amount of ANT was obtained by densitometry from Western blots performed on mitochondria isolated from different rat tissues using a polyclonal antibody. The results are expressed as total band intensity relative to the muscle signal. ANT1 isoform quantities were determined by Western blotting with a specific antibody and expressed relative to the muscle signal. ANT1 amount, ANT2 amount, and ANT1 amount normalized by muscle signals (*) have been calculated from ANT1/ANT2 ratio of mRNA obtained by quantitative PCR on rat tissues (28) . Results are presented as mean Ϯ S.E. (n ϭ 5). 
FIG. 3. Absolute amounts of total ANT and ANT1 isoforms vary in different tissues.
A, the total amount of ANT from different rat tissues was determined by Western blots from SDS-PAGE on gradient 10 -22% polyacrylamide gels immunoblotted with polyclonal ANT abs and anti-Porin (31HL). Total band intensity of ANT was determined by densitometry and shown on the bar graphs. B, the same procedure was carried out with anti-ANT1 (Ab2) and anti-Porin (31HL) abs. Amounts of mitochondrial protein used are indicated. Results are shown as in the bar graphs and presented as mean Ϯ S.E. (n ϭ 5).
these conditions, D 1 was mainly associated with Porin, but also in a free state (35 kDa). Moreover, D 1 was completely dissociated from the macrocomplex (Ͼ300 kDa) in muscle. ANT1/ Porin ratios remained constant in a given tissue, irrespective of the respiratory substrates.
We compared these results on muscle with those obtained on heart and kidney mitochondria. In the heart, D 1 and M 1 forms were present but not 2D 1 . In the kidney, the amounts of 2D 1 and D 1 were similar, whereas M 1 was absent or undetectable (Fig.  5B) . Moreover, there was no change in the proportion of each form in heart as in kidney according to the different substrates. We conclude that the distribution of ANT1 oligomers depends on tissue type as well as monomer recruitment.
ANT1 Associated in the Mitochondrial Permeability Transition Pore Complex Is Mobilized in Response to an Increase in the Respiratory
Rate-Several studies demonstrate that ANT1 is a core component of the mitochondrial permeability transition pore complex (32, 33) . We investigated whether the mobilization of the ANT1 in this structure could explain part of the I max increase observed in muscle by inhibiting respiration with CATR on pyruvate-malate or succinate, with or without 10 M cyclosporin A (CsA) (Fig. 6, A and B) . Under these conditions, I max increased by 59% with CsA on pyruvate-malate but not on succinate (Table I) . To verify the molecular origin of this increase, we performed Western blots on the 2D gels obtained on muscle mitochondria respiring on pyruvate-malate with or without CsA (Fig. 6C) . We used two abs that recognize different regions of ANT1: Ab1 is specific for the N-terminal domain (N ter ), whereas Ab2 is localized in the second matrix loop, as described in most accepted models of ANT topology (34 -36) . 2D gel patterns showed that Ab2 recognized 55 kDa dimers (D 2 ) associated in a complex higher than 300 kDa on the first dimension, but also 32 kDa monomers of (M 2 ) (Fig. 6C) . The N ter domain of this new dimer D 2 was inaccessible to Ab1 (as for M 2 ), suggesting that the carrier had two distinct dimeric conformations (D 1 and D 2 ) . Moreover, on the second dimension, this change was followed by a difference in the electrophoretic migrations between D 1 and D 2 . The quantification results ob- FIG. 4 . Several ANT1 oligomers exist in muscle mitochondria respiring on pyruvate-malate under phosphorylating conditions. A, 2D gel analysis of muscle mitochondria (300 g of proteins) solubilized by n-dodecylmaltoside respiring on pyruvate-malate with 2 mM ADP by BN-PAGE 10% polyacrylamide slab gel. Western blots were carried out using complex III Core 2, cytochrome c oxydase IV of complex IV, complex II 70-kDa subunit, and Porin (31HL) abs. Western blot of the second dimension (SDS/PAGE) using ANT1 (Ab1) and Porin (31HL) abs. Molecular mass markers are shown. B, 2D gel analysis of muscle mitochondria respiring on pyruvate-malate with 2 mM ADP and solubilized by digitonin, anti-COX IV with anti-Porin (31HL) abs were used. Western blot of the second dimension was carried out using either anti-Porin (31HL) (right gel), or anti-ANT1 (Ab1), and anti-Porin (31HL) abs (left gel). M1, ANT1 monomers; D 1 , ANT1 dimers; 2D 1 , ANT1 coupled dimers. C, same procedure as in B, but proteins were stained with Sypro Ruby. The spots shown were cut and analyzed by tandem mass spectrometry, Xcorr are indicated.
tained by densitometry demonstrated a constant amount of M 1 and M 2 , irrespective of the presence of CsA (Fig. 6D) . However, the amount of D 1 was halved with CsA, whereas D 2 increased to the same extent (67.5% more with CsA). CsA did not have a significant effect on the 2D 1 form, suggesting a conformational change of D 1 to D 2 after CsA addition. As control of quantification, ANT1/porin ratios (M 2 ϩD 2 /porin without CsA) on pyruvate-malate in muscle and the ANT1/porin ratio in muscle calculated from Fig. 3B (0.85 Ϯ 1.1 and 0.91 Ϯ 1.4, respectively) remained constant. We carried out a BN-PAGE on gradient gels (Fig. 6C) to determine more precisely whether D 1 and D 2 were associated in the same complex. The two patterns without CsA showed a colocalization of D 1 , Porin and cyclophilin D (CyD) associated in a 600-kDa complex. D 2 is also found to be associated with Porin but not CyD in a smaller complex of 400 kDa. CyD was not observed in free state on the first dimension but totally bound to macrocomplexes over 300 kDa (data not shown). It is interesting that CsA dissociated CyD from the 600-kDa complex, although not completely. The 35% remaining CyD was associated with D 1 . These results suggest that MPTP closure with CsA induces ANT1 to change its conformation from D 1 to D 2 in a complex including Porin and CyD. This increases the amount of functional ANT1 involved in the nucleotide exchange activity.
DISCUSSION
The threshold effect observed in mitochondrial OXPHOS has profound implications for the diagnosis and pathogenesis of mitochondrial disorders. Indeed, this biochemical threshold effect partially controls the phenotypic expression of OXPHOS defects and therefore contributes to the variability observed in the clinical presentation and severity of mitochondrial disorders. However, the molecular mechanisms responsible for this threshold have yet to be clarified, particularly at the biochemical level. We recently proposed that excess enzyme activity for the OXPHOS complexes could explain the plateau phase of FIG. 5 . Tissue specificity distribution of ANT1 oligomers on various respiratory substrates. A, 2D gel analysis of mitochondria isolated from muscle, heart, and kidney solubilized with digitonin (digitonin/protein ratio of 3 g/g) and respiring at state 3 (ADP 2 mM) on pyruvate-malate, or succinate, or ascorbate-TMPD, or pyruvate-malate in presence of 2 M CCCP. Second dimensions were immunoblotted with anti-ANT1 (Ab1) and anti-Porin (31HL) abs. B, the amount of ANT1 monomers M 1 , dimers D 1 , and coupled dimers 2D 1 was determined by densitometry and normalized by Porin signals (ANT1/Porin). Results are presented in the bar graphs as mean Ϯ S.E. (n ϭ 3). *, p Ͻ 0.05 versus 2D 1 on pyruvate-malate; **, p Ͻ 0.05 versus 2D 1 on succinate; #, ANT1 forms not detectable.
FIG. 6.
CsA-induced increase in functional ANT is based on the conformational change of the carrier. State 3 respiratory rate CATR titration curves of muscle mitochondria respiring (A) on 10 mM pyruvate and 10 mM malate or (B) 25 mM succinate with 0.4 g/ml rotenone with (q) or without (Ⅺ) 10 mM CsA or in absence. C, 2D gel analysis of the effect of CsA on the ANT1 oligomeric states: muscle mitochondria respiring on pyruvate-malate and ADP with or without 10 mM CsA were solubilized by digitonin/protein ratio of 3g/g and BN-PAGE using 5-13% acrylamide-bis gradient gels (gels to the left) and 10% (gels to the right). OXPHOS complexes (I, III, IV, V) and "supercomplexes" (a, b) mentioned by (31) type I threshold curves (3) . This notion of excess activity has already been observed with cytochrome c oxidase (7, 37) . In this study, we demonstrated this excess for ANT and its molecular origin constituted 1) by a mobilization of inactive ANT1 subunits able to constitute new oligomeric active carriers and 2) by conformational changes of ANT1 in a PTP-like structure.
The functional ANT involved in mitochondrial respiration were quantified using CATR, which binds only to the active form of ANT. We observed that the amount of functional ANT in muscle and brain mitochondria increased with respiration compared with that in other tissues, indicating a reserve of mobilizable carriers. These newly involved carriers (inducing an increase in V max ) maintained an excess of enzyme activity through several respiratory steady states. Accordingly, ANT activity can be 90% inhibited in muscle and brain with only slight repercussions on JO 2 , leading to high threshold values. In contrast, liver and kidney, where no mobilization was observed, were unable to compensate for ANT inhibition by CATR when respiration increased, so their threshold values are low. We also observed this mechanism in human muscle fibers, indicating the relevance of this phenomenon in the cell context, in that it is possible to maintain high threshold values irrespective of the respiration state. Thus, ANT mobilization may be one parameter that can determine the threshold value.
Because this ANT mechanism was tissue-specific, the ANT1 versus ANT2 balance between tissues may partly explain this recruitment. In our study, muscle and heart had the same threshold curves and amount of carriers involved on pyruvatemalate respiration (Fig. 1B) , whereas only muscle mobilized on succinate. However, the ANT2 content was twice as high in heart as it was in muscle (Table II) , whereas the associated respiration was relatively similar. The larger amount of isoform 2 observed in heart maintained type I curves without any mobilization between the various substrates, contrary to muscle. Muscle may mobilize isoform 1 to compensate for this lower amount of ANT2 (Fig. 5A) . These findings are supported by data obtained from the transgenic mouse model for mitochondrial diseases lacking the ANT1 isoform, where muscle mitochondria showed a dramatic decrease in respiration on pyruvate; this decrease was further accentuated on succinate, whereas it remained completely unchanged in heart mitochondria (38) . Moreover, muscle and kidney present the same amount of ANT2 but muscle, unlike kidney, is able to mobilize enough ANT1 to maintain type I curves. Likewise, brain maintains type I curves by recruiting its pool of ANT1 (3.4-fold more important than kidney). Thus, the more ANT2 is expressed, the less the tissue needs to mobilize ANT1 (in the case of heart and muscle). This implies that isoform 2 may present the highest catalytic efficiency and isoform 1 the greatest capacity to be mobilized. Recent studies emphasize this hypothesis, indicating that human ANT1 has a lower V max than ANT2 (39) but is also modulated by cell energy demand (29) , whereas ANT2 is weakly expressed in normal tissues but strongly induced in highly proliferative cells (40) . Their distinct cell regulation of isoform expression (40 -42) and phosphorylation pattern (43) strongly linking ANT1 with OXPHOS activity. Thus, correlated with our study for this tissue, this isoform-specific signal of phosphorylation could maintain ANT1 inactive in the respiratory function (43) . Consequently, despite their close peptide sequences, these isoforms may support distinct functions, but we cannot exclude the possibility of ANT2 mobilization.
Our results support this observation and demonstrate that isoform 1 may be sensitive to respiratory chain activity transitions. It is correctly assumed that the functional carrier is a homodimer, unlike monomers, which are not capable of ADP/ ATP exchange (44) . However a higher state of oligomerization, such as assembled or coupled dimers, was also proposed on the basis of 1) nucleotide binding data (45, 46) and 2) observation of its native insertion with the transport inner membrane-transport outer membrane import system (47). We were able to visualize various oligomeric forms, such as D 1 dimers, but also 2D 1 coupled dimers. Moreover, a large amount of inactive ANT1 monomers is present in tissues that express this isoform strongly, such as muscle and heart, but seems to be absent from kidney.
We showed that the increase in functional ANT observed in muscle mitochondria after an increase in respiration was associated with a total loss of M 1 in favor of 2D 1 synthesis. This illustrates that the ANT1 coupled dimers are newly implicated in respiration. This was not the case in heart and kidney mitochondria; their I max was unchanged. In kidney on pyruvate, all the ANT1 is apparently already involved in dimers, whereas coupled dimers are absent from heart. Because no I max variation or monomer mobilization was observed in heart mitochondria, we confirmed that the amount of ANT2 was still sufficient to maintain an excess of activity in all steady states. Recent work on the protein import pathway in yeast reported that newly inserted monomeric ANT1 in the inner membrane was only able to dimerize with a pre-existing monomeric ANT, but there is also a dynamic equilibrium between dimerization and disassociation. This transition occurs in less than 1 min, as found in this study during the steady state, and is dependent on the native cysteine residues (48) . In this work, we report the presence of OXPHOS subunits sensitive to respiratory chain activity modulations that are able to interact rapidly and create new active oligomers. This observation confirms the existence of an enzyme reserve and provides a molecular explanation for the plateau phase in type I threshold curves. The capacity to mobilize this reserve may explain the origin of new ANT involved in respiration in muscle and, probably, brain. However, the molecular signals inducing this phenomenon are still difficult to define. These associations seem to be sensitive of modulations in mitochondrial membrane potential, in that addition of carbonylcyanid-m-chlorophenylhydrazon dissociates the ANT1 oligomers and their interactions with other proteins (CyD and Porin). Thus, mitochondrial membrane potential (or ⌬pH) might control this assembly, may be by acting on cardiolipin, which interacts with labeling bovine heart cysteine 56 (49) required for nucleotides exchange activity (50) .
Furthermore, the results obtained with CsA show that this reserve may also consist of ANT1 dimers combined in the mitochondrial permeability transition pore complex. Several authors have described this carrier as a core component of this complex responsible for the mitochondrial induction step in apoptosis (32) . Recent work reports that overexpression of ANT1, but not ANT2, is a dominant factor in inducing apoptosis in mammalian cells (51) . In our study, it was possible to distinguish between the so-called cytosolic (required for permeability transition) and matricial conformations (52-54) by using two abs (Ab1 and Ab2). The presence of CsA, which strongly removed CyD from the 550 -600-kDa complex, induced a change from D 1 to D 2 state. The absence of CyD, correlated with the D 2 state, characterizing the new 400-kDa complex. The latter structure (without CyD) seems to be involved in respiration as CsA, an inhibitor of PTPC opening (55) , induce the conformational modification in ANT1 dimers necessary for their exchange activity. ANT1 remodeling is the second mechanism, which also depends on respiratory chain activity. In addition to M 1 assembly, this may explain the origin of new functional ANT mobilized during an increase in respiration from pyruvate-malate to succinate.
To summarize, we report here a new mechanism consisting of a reserve of enzymes not initially involved in the respiratory rate. In the case of ANT1, mobilization can be triggered by assembling free ANT1 subunits to form new carriers, as well as a change from inactive to active conformation of the carrier (Fig. 7) . However, the contribution of each mechanism to this mobilization process has yet to be clarified. In view of its kinetic properties, ANT2 is likely to be strictly in charge of ADP/ATP exchange, whereas ANT1 may be involved in other structures, recovering its exchange function according to energy cell requirements. The ANT1 isoform may thus adapt to various tissue metabolisms (long-term adaptation with tissue expression) as well as different states of functioning in the same tissue (short-term adaptation with recruitment). This regulation of the number of enzymes enrolled would maintain a large excess of activity, depending on the energy substrates, and thus abolish the expression of activity defects of the carrier. This is important from a physiological standpoint because tissues do not use the same respiratory substrate.
A similar mechanism has recently been reported for complex I, demonstrating the existence of active and inactive forms distinguished by two distinct kinetic and structural properties (56, 57) . Moreover, dimeric complex III would be composed of active and "silent" monomers for the interaction with cytochrome c that could be regulated by the binding level of ubiquinone in its reduction site (58) . As recently described, the dimerization of ATP synthase may be regulated by the matricial pH-dependent binding of the inhibitor IF1 (59), and its oligomerization was shown to be implicated in the morphology of mitochondrial cristae (60) . These data suggest that a similar mobilization mechanism may also occur in these complexes; by extension, these oligomeric transitions may play a crucial role in OXPHOS function regulation. This emphasizes the contribution of supramolecular structure modulations in the expression of OXPHOS defects in respiratory chain activity and, consequently, in the understanding of mitochondrial diseases.
